Expo Hub
Empowering Hope: Imaging Alzheimer’s in the Era of Disease-Modifying Therapies – A Siemens Healthineers Symposium
About the session
Alzheimer’s disease is undergoing a paradigm shift - with disease-modifying therapies (DMTs) transforming care pathways and increasing the demand for precise, efficient imaging. This symposium explored how advanced imaging and technological innovations help clinicians meet these evolving diagnostic and operational requirements - supporting earlier diagnosis, standardized quantification, therapy monitoring, and streamlined workflows across care settings.
1 / 0
Felix Eisenhut
Siemens Healthineers, Erlangen, Germany
Tammie Benzinger
Professor of Radiology and Neurological Surgery at Washington University in St. Louis, Chief of MRI at the Mallinckrodt Institute of Radiology, USA
Jana Ivanidze
Associate Professor of Radiology, Weill Cornell Medical College, NY, USA
Suzie Bash
Medical Director of Neuroradiology at RADNET at San Fernando Valley Interventional Radiology, USA
1 / 0
Alzheimer's disease
Learn how MRI can help in Alzheimer's disease follow-up.
BIOGRAPH One*
Shape the new era
PET imaging for Alzheimer's disease
Siemens Healthineers PETNET, positioned to support the identification of Alzheimer's disease in its earliest stages.
PET/CT scanners
Set the standard in PET/CT with our BiographPET/CT family.
* BIOGRAPH One is pending 510(k) clearance and is not yet commercially available in the U.S.A. Its future availability cannot be guaranteed